Reporting COVID19 Cases into the ELSO Registry.
In an effort to better understand the impact of COVID19 on ECMO we have added a question asking if a patient has COVID19. Confirmed COVID-19 cases should utilize the ICD-10 emergency code U07.1, 2019-nCoV acute respiratory disease as the primary diagnosis. The COVID-19 addendum is now available. Please enter your cases when they go on ECMO and update record as needed.
There are 4 response options.
COVID19 confirmed by testing
COVID19 suspected but NO testing
No clinical suspicion of COVID19 (and no testing)
COVID19 confirmed negative
ECMO Capacity Map
ELSO has developed a map that quickly shows ECMO capacity (map: https://www.elso.org/Membership/CenterMap.aspx). Center administrators can update the capacity here: http://www.elso.org/UpdateECMOCapacity) or from the Manage - Manage Center Details section. Please download a new app (search for: ELSO Update ECMO Capacity) on your mobile device for efficient capacity status communication, which should be available very soon.
The ELSO Board of Directors is pleased to announce the addition of Christine Stead as Interim CEO.
Ms. Stead holds a Bachelor of Science degree in Cellular & Molecular Biology from the University of Michigan and a Master of Health Services Administration in Health Management and Policy, also from the University of Michigan. She has spent the last 20 years in management consulting with a wide variety of healthcare-related customers, focusing on strategy with a strong operational foundation.
According to ELSO’s President, Dr. Mark Ogino “We look forward to Christine leveraging her considerable management experience for the benefit of ELSO, as we chart our course for the future.”
With the guidance of its Executive Director, Peter Rycus, ELSO has achieved significant growth on an international scale, both in terms of revenue and membership. The addition of Ms. Stead will allow ELSO to continue this growth while expanding its leadership role in other related areas. Ms. Stead will provide leadership in defining and implementing the organizational structure needed to achieve these goals.
Certification
Dear ELSO Member,
The Extracorporeal Life Support Organization (“ELSO”) is committed to protecting your privacy and information. Recently an organization, DNV-GL, sent an email messages to ELSO members soliciting participation in their DNV GL ECLS Certification Program. This email was not endorsed or authorized by ELSO and ELSO did not provide its mailing list to the sender. The use of email addresses or other identifying information of ELSO website users for any purpose not specifically authorized by ELSO is strictly prohibited by the website Terms of Use. ELSO has no knowledge of the content or quality of the program offered by DNV-GL and does not endorse or have a relationship with DNV-GL.
ELSO is dedicated to the development and evaluation of novel therapies for support of failing organ systems and provision of education, training, research, and data management for the advancement of extracorporeal life support throughout the world. Toward that end, ELSO currently offers the ELSO Award for Excellence in Life Support to qualified ELSO member centers that wish to receive designation as a Center of Excellence in Life Support. Centers that meet the criteria are welcome to apply and if successful are recognized as distinguished leaders in critical care. The ELSO Award for Excellence is recognized by the US News and World Report and Parents magazine as one criterion for top institutions providing ECLS.
ELSO’s goal is to recognize and honor ECLS programs that meet or exceed performance, innovation, satisfaction and quality levels defined by ELSO member centers through a broad certification program to be launched soon. Please join us in Hawaii for our 31st Annual ELSO meeting, where we will announce an exciting new process to recognize ECLS Centers.
Mark T Ogino, MD
ELSO | President (2018-2020)
Extracorporeal Life Support Organization